Rationalizing the study of plants for the treatment of oral pain

Current Chemical Biology

Volumn 2, Issue 2, 2008, Pages 140-152

  Colvard, Michael D ^a   Cordell, Geoffrey A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Ethnomedicine; Oral pain; Traditional medicine standardization

Indexed keywords

ALKALOID DERIVATIVE; AMINOPHENAZONE; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIULCER AGENT; ARECOLINE; AZATHIOPRINE; BENZOCAINE; CAFFEINE; CAPSAICIN; CHALCONE DERIVATIVE; CHROMENE DERIVATIVE; CLOVE OIL; COCAINE; CODEINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ESSENTIAL OIL; FLAVONOID; INDOMETACIN; LIDOCAINE; MORPHINE; PILOCARPINE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; SESQUITERPENE; TERPENE DERIVATIVE; THALIDOMIDE; UNINDEXED DRUG;

ANALGESIA; ANTIINFLAMMATORY ACTIVITY; APHTHOUS ULCER; BILE DUCT OBSTRUCTION; DENTAL CARE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG INDUSTRY; DRUG ISOLATION; DRUG MECHANISM; DRUG QUALITY; DRUG RESEARCH; DRUG RESPONSE; DRUG SAFETY; DRUG STORAGE; DRUG STRUCTURE; DRUG SYNTHESIS; EVIDENCE BASED MEDICINE; HEALTH SURVEY; HUMAN; MAXILLOFACIAL DISORDER; MEDICINAL PLANT; MOUTH INFLAMMATION; MOUTH PAIN; NEURALGIA; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PLANT LEAF; PLANT ROOT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SHELF LIFE; SIDE EFFECT; STANDARDIZATION; SWEATING; TRADITIONAL MEDICINE;

MAMMALIA;

EID: 48249083873     PISSN: 18723136     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231308784220545     Document Type: Review

References (188)

1. Farnsworth NR. The role of ethnopharmacology in drug development. Ciba Foundation Symposium 1990; 154: 2-11; discussion 11-21.
2. Foster S, Duke, JD. The Peterson Field Guide Series: A Field Guide to Medicinal Plants, Eastern and Central North America. Boston, Houghton Mifflin Co. 2000.
3. Cordell GA, Beecher CW, Pezzuto JM. Can ethnopharmacology contribute to the development of new anticancer drugs? J Ethnopharmacol 1991; 32:117-33.
4. Farnsworth NR. Ethnopharmacology and future drug development: the North American experience. J Ethnopharmacol 1993; 38: 145-52.
5. The Complete Parallel Bible. Oxford, Oxford University Press. 1989.
6. Dix G. The Treatise on the Apostolic Tradition of St. Hippolytus of Rome. London, Alban Press. 1991.
7. Ferguson E. The Encyclopedia of Early Christianity. 2nd ed. London, Garland Publishing. 1999. p 56.
8. Wiley P, Hofman JL. Interproximal grooves, toothaches, and purple coneflowers. In: Owsley DW, Jantz RL Eds., Skeletal Biology in the Great Plains: Migration, Warfare, Health, and Subsistence. Chicago, University of Chicago Press. 1994. pp. 147-157.
9. Murray MT, Pizzorno J. Encyclopedia of Natural Medicine, 2nd ed. California, Prima Publishing. 1998.
10. Senn HA. Jungian shamanism. J Psychoact Drugs 1989; 21: 113-21.
11. Begley SS. Tibetan Buddhist medicine: a transcultural nursing experience. J Holist Nurs 1994; 12: 323-42.
12. Barnes LL. The psychologizing of Chinese healing practices in the United States. Cult Med Psych 1998; 22: 413-43.
13. McElroy A, Townsend P. Medical Anthropology in Ecological Perspective, 2nd ed. Boulder, Westview Press 1985; p 15.
14. Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy. Bull WHO 1985; 63: 965-81.
15. World Population Clock at www.ibiblio.org/lunarbin/worldpop
16. Cordell GA, Colvard MD. Some thoughts on the future of ethnopharmacology. J Ethnopharmacol 2005; 100: 5-14.
17. Iraskin I, Ribnicky D, Komamytsky S, et al. Plants and human health in the twenty-first century. Trends Biotechnol 2002; 20: 522-531.
18. Anonymous. WHO First Global Strategy on Traditional and Alternative Medicine. World Health Organization, Geneva, Switzerland. 2002.
19. Anonymous. PAHO Traditional, Complementary, and Alternative Medicines and Therapies: Evaluation Plan of Work 2000-2001 and Evaluation Plan of Work 2002-2003. Pan American Health Organization. 2002.
20. Millennium Ecosystem Assessment. Ecosystems and Human Well-being: Synthesis, Island Press, Washington, DC, World Resources Institute. http://www.millenniumassessment.org/en/products.aspx, 2005. p. 13.
21. Zajicek G. Wisdom of the body. Med Hypoth 1999; 52: 447-9.
22. Sparber A, Bauer L, Curt G, et al. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum 2000; 27: 623-30.
23. Chevallier A. The Encyclopedia of Medicinal Plants: A Practical Reference Guide to More Than 550 Key Medicinal Plants and Their Uses. 1st American ed. New York, Dorling Kindersley Publications. 1996.
24. Plotkin M. Medicine Quest. New York, Penguin Books. 2000; 21.
25. Sullivan R, Hagen E. Psychotropic substance seeking: Evolutionary pathology or adaptation. Addiction 2002; 97: 389-400.
26. Wink M. Allelochemical properties or the raison d'etre of alkaloids. In: Cordell, GA Ed. The Alkaloids Chemistry and Biology. San Diego, Academic Press. 1993; 43: 1-118.
27. Nebert DW, Dieter MZ. The evolution of drug metabolism. Pharmacology 2000; 61: 124-35.
28. Casagrande D. Human taste and cognition in the Tzeltal Maya medicinal plant use. J Ecol Andiropol 2000; 4: 57-69.
29. Colvard. MD, Cordell, GA, Villalobos R, et al. Survey of medical ethnobotanicals for oral medicine conditions and pathologies. J Ethnopharmacol 2006; 107: 134-142.
30. Yatsu M. Miscellaneous records of medico-dental and pharmacological history: Secret book on oral medicine published in 1762. Shikai Tenbo 1985; 66: 1138-9.
31. American Pharmaceutical Association. Practical Guide to Natural Medicines. New York, Stone Song Press. 1999.
32. Jellin J, Batz F, Hitchens K. Pharmacist's Letter/Prescribers Letter Natural Medicines Comprehensive Database. Stockton, CA, Theraputic Research Faculty. 1999.
33. Gage T, Pickett F. Mosby's Dental Drug Reference, 5th ed. St. Louis, Mosby, 2001.
34. Wynn R, Meiller T, Crossley H. Drug Information Handbook for Dentistry: Oral Medicine for the Medically Compromised Patients and Specific Oral Conditions. 6t' ed. Hudson Ohio, Lexicomp. 2000.
35. Basbaum AI, Jessel T. The perception of pain. In: Principles of Neuroscience. Kandel ER Ed, New York, McGraw-Hill, 2000.
36. Cordell GA. Biodiversity and drug discovery - a symbiotic relationship. Phytochemistry 2000; 55: 463-480.
37. Cordell GA. Changing strategies in natural products chemistry. Phytochemistry 1995; 40: 1585-1612.
38. Soejarto DD, Farnsworth NR. Tropical rain forests: Potential source of new drugs? Persp Biol Med 1989; 32: 244-256.
39. Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Hlth Persp 2001; 109: 69-75.
40. Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 2003; 66: 1022-1037.
41. Eskinazi D. Methodologic considerations for research in traditional (alternative) medicine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 678-81.
42. Colvard. M, Kuo P. Managing aphthous ulcers: Laser treatment applied. JADA 1991; 122: 51-53.
43. Pick B, Colvard. M. Current status of lasers in soft tissue dental surgery. J Perio 1993; 64: 589-602.
44. Pomeranz B. Acupuncture and the endorphins. Ethos 1982; 10: 358-393.
45. Zhai D, Din B, Liu R, Hua X, Chen H. Regulation on ACTH, beta-EP and immune function by moxibustion on different accupoints. Chen Tzu Yen Chiu 1996; 21: 77-81.
46. Lukoff D, Provenzano R, Lu F, Turner R. Religious and spiritual case reports on MEDLINE: a systematic analysis of records from 1980 to 1996. Alt Ther Hlth Med 1999; 5: 64-70.
47. Jacobsen PL, Cohan RP. Alternative dental products. J Calif Dent Assoc 1998; 26: 191-8.
48. Ocasio, NA, Solomowitz BH, Sher MR. Natural remedies recommended for the management of oral health. NY State Dent J 1999; 65: 22-4.
49. Sakagami H, Oi T, Satoh K. Prevention of oral diseases by polyphenols. In Vivo 1999; 13: 155-71.
50. Schmidgall J, Schnetz E, Hensel A. Evidence for bioadhesive effects of polysaccharides and polysaccharide-containing herbs in an ex vivo bioadhesion assay on buccal membranes. Planta Med 2000; 66: 48-53.
51. Boisyvon MY. Use of plants in dental therapeutics and current oral medicine. Inf Dent 1986; 68: 3309-14.
52. Garnick JJ, Singh B, Winkley G. Effectiveness of a medicament containing silicon dioxide, aloe, and allantoin on aphthous stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 550-6.
53. Ammar N, Gaafar S, Khalil R. Anti-inflammatory effect of natural steroid sapogenins on oral aphthous ulcers. Egypt Dent J 1992; 38: 89-98.
54. Bos R, Hendriks H, van Os FH. The composition of the essential oil in the leaves of Coleus aromaticus Bentham and their importance as a component of the species. Pharm Weekblad Sci 1983; 5: 129-30.
55. Qunqiang L, Farnham S. Clinical experience with Chinese herbs in endodontic therapy. Gen Dent 1989; 37: 234.
56. Hayes SM. Lichen planus port of successful treatment with aloe vera. Gen Dent 1999; 47: 268-72.
57. Hijikata Y, Tsukamoto Y. Effect of herbal therapy on herpes labialis and herpes genitalis. Biotherapy 1998; 11: 235-40.
58. Karimi K. The impact of current alternative herbal remedies on dental patient management. Gen Dent 1999; 47: 264-6.
59. Harshberger JW. Purposes of edmobotany. Bot Gaz 1896; 21: 146-154.
60. Solecki R, Shanidar IV. A Neanderthal flower burial in northern Iraq. Science 1975; 190: 880-1.
61. Oxenham MF, Locher C, Cuong NL, Thuy NK. Identification of Areca catechu (Betel nut) residues on the dentition of Bronze age inhabitants of Nui Nap, Northern Vietnam. J Archeol Sci 2002; 29: 909-915.
62. Schultes RE. Mexico and Colombia: two major centers of aboriginal use of hallucinogens. J Psych Drugs 1977; 9: 173-176.
63. Cordell GA. Introduction to Alkaloids: A Biogenetic Approach. New York, Wiley-Interscience. 1981; 1055.
64. Johns T. With Bitter Herbs, They Shall Eat It: Chemical Ecology and the Origins of Human Diet and Medicine. Tucson, The University of Arizona Press. 1990.
65. Wink M. Chemical ecology of alkaloids. In: Roberts MF, Wink M Eds, Alkaloids: Biochemistry, Ecology, and Medicinal Applications. New York, Plenum Press. 1998; 265-300.
66. Wink M. Modes of action of alkaloids. In: Roberts MF, Wink M Eds. Alkaloids: Biochemistry, Ecology, and Medicinal Applications. New York, Plenum Press. 1998; 301-326.
67. Wink M. A short history of alkaloids. In: Roberts MF, Wink M Eds. Alkaloids: Biochemistry, Ecology, and Medicinal Applications. New York, Plenum Press. 1998; 1-44.
68. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001; 413: 203-210.
69. McMahon SB, Cafferty WB, March F. Immune and glial factors as pain mediators and modulators. Exptl Neurol 2005; 192: 444-462.
70. Martin WJ, Loo CM, Basbaum AI. Spinal cannabinoids are anti-allodynic in rats with persistent inflammation. Pain 1999; 82: 199-205.
71. Guan JS, Xu, ZZ, Gao H, et al. Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia. Cell 2005; 122: 619-631.
72. Nakatsuka T, Chen M, Takeda D, et al. Substance P-driven feed-forward inhibitory activity in the mammalian spinal cord. Mol Pain 2005; 1: 20-29.
73. Yang BH, Piao, ZG, Kim YB, et al. Activation of vanilloid receptor 1 (VR1) by eugenol. J Dent Res 2003; 82: 781-785.
74. Baustista DM, Jordt SE, Nikai T, et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 2006; 124: 1269-1282.
75. Muller M, Pape HC, Speckmann EJ, Gorji A. Effect of eugenol on spreading depression and epileptiform, discharges in the rat neocortical and hippocampal tissues. Neuroscience 2006; 140: 743-751.
76. Kidd BL, Urban LA. Mechanisms of inflammatory pain. Brit J Anaesth 2001; 87: 3-11.
77. Woolf CJ, Salter MW. Plasticity and pain: role of the dorsal horn. In: McMahon SB, Klotzenburg M, eds. Wall and Melzack's Textbook of Pain. Philadelphia, PA: Elsevier Churchill Livingstone. 2005: 91-205.
78. Daffonchio L, Novellini R, Bertuglia S. Protective effect of ketoprofen lysine salt on interleukin-1 beta and bradykinin-induced inflammatory changes in hamster cheek pouch microcirculation. Inflamm Res 2002; 51: 223-8.
79. Yagiela JA, Dowd FJ, Neidle EA. Pharmacology and Therapeutics for Dentistry 5th ed., St. Louis, Elsevier Mosby. 2004; pp 764.
80. Coppa A, Bondioli L, Cucina A, et al. Paleontology: early Neolithic tradition of dentistry. Nature 2006; 440: 755-6.
81. Ramoutsaki IA, Askitopoulou H, Konsolaki, E. Pain relief and sedation in Roman Byzantine texts: Mandragora officinarum, Hyoscyamus niger, and Atropa belladonna. Int Congr Ser 2002; 1242: 43-50.
82. Martin-Duce A. A developmental history of local anesthesia. Amb Surg 2002; 9: 187-189.
83. Goodman J. Tobacco in History: The Cultures of Dependence. London, Routledge. 1994. p. 29.
84. Shipard, I. How can I use herbs in my daily life? Nambour, Australia, Shipard's Herb Farm. 2005; pp.378.
85. Lloyd JU, Lloyd JT. Coca, the divine plant of the Incas. History of the vegetable drugs of the pharmacopeia of the United States. Lloyd Lib Bull Num 18, 1911.
86. Rodriguez N, Rodriguez M, Calderon AI, Feliciano AS, Solis PN, Gupta MP. Anesthetic activity of pipercallosine isolated from Piper darienense. Rev Latinoamer Quim 2005; 33: 115-120.
87. Cordell GA, Araujo OA. Capsaicin: identification, nomenclature and pharmacotherapy. Ann Pharmacother 1993; 27: 330-336.
88. Padilla M, Clark GT, Merrill RL. Topical medications for orofacial neuropathic pain: a review. JADA 2000; 2: 184-195.
89. Cordell GA. Natural products in drug discovery-Creating a new vision. Phytochem Rev 2002; 1: 261-273.
90. Cordell GA. Discovering our gifts from nature, now and in the future. part I. Rev Quim 2002; 16: 5-12.
91. Cordell GA. Biodiversity, Traditional Medicine, and Drug Discovery - A Symbiotic Relationship, In: Proceedings of the 1st International Congress on Traditional Medicine & Materia Medica, Shaheed Beheshti University of Medical Sciences & Health Services, Tehran, Iran. 2002. p 21-34.
92. Cordell GA. Discovering Our Gifts from Nature, Now and in the Future. Part II. Rev Quim 2003; 17: 1-15.
93. Cordell GA. Some thoughts on the standardization of traditional medicines. Thai J Hlth Res 2004; 18: 87-105.
94. Cordell GA. Accessing our gifts from nature, now and in the future. part III. Rev Quim 2004; 19: 33-41.
95. Borman S. Improving efficiency. Chem Eng News 2006; June 16: 56-78.
96. Hileman B. Regulatory trends. Chem Eng News 2006; June 16: 80-99.
97. Yatsu M. Miscellaneous records of medico-dental and pharmacological history: secret book on oral medicine published in 1762. Shikai Tenbo 1985; 66: 1138-1139.
98. Subapriya R, Nagini S. Medicinal properties of neem leaves: a review. Curr Med Chem Anticancer Agents 2005; 5: 149-6.
99. de Armas E, Sarracent Y, Marrero E, Fernandez O, Branford-White C. Efficacy of Rhizophora mangle aqueous bark extract (RMABE) in the treatment of aphthous ulcers: a pilot study. Curr Med Res Opin 2005; 21: 1711-1715.
100. Rodriques E. Plants and animals utilized as medicine in the Jau National Park (JNP), Brazilian Amazon. Phytother Res 2006; 20: 378-391.
101. Tapsoba H, Deschamps JP. Use of medicinal plants for the treatment of oral diseases in Burkina Faso. J Ethnopharmacol 2006; 104: 68-78.
102. Karp A, Seberg O, Buiatti M. Molecular techniques in the assessment of botanical diversity. Ann Bot 1996; 78: 143-149.
103. Kroes R, Walker R. Safety issues of botanicals and botanical preparations in functional foods. Toxicology 2004; 198: 213-220.
104. Berman JD, Straus SE. Implementing a research agenda for complementary and alternative medicine. Ann Rev Med 2004; 55: 239-254.
105. Flores CM, Leong AS, Dussor GO, Harding-Rose C, Hargreaves KM, Kilo S. Capsaicin-evoked CGRP release from rat buccal mucosa: development of a model system for studying trigeminal mechanisms of neurogenic inflammation. Eur J Neurosci 2001; 14: 1113-20.
106. Raboisson P, Dallel, R. The orofacial formalin test. Neurosci Behav Rev 2004; 28: 219-26.
107. Alonge OK, Ashrafi SH, Colvard MD. Mitochondrial volume densities in the smokeless tobacco treated hamster cheek pouch epithelium. Oral Dis 2003; 9: 138-143.
108. Colvard MD, Ashrafi SH, Alonge OK, Cordell GA. Smokeless tobacco-induced lamellar body abnormalities. Oral Dis 2006; 12: 343-8.
109. Ogura M, Cordell GA, Quinn ML, et al. Ethnopharmacologic Studies. I. Rapid solution to a problem-oral use of Heliopsis longipes - by means of a multidisciplinary approach. J Ethnopharmacol 1982; 5: 215-219.
110. Makapugay H, Soejarto DD, Kinghom AD, Bordas E. Piperovatine, the tongue-numbing principle of Ottonia frutescens. J Ethnopharmacol 1983; 7: 235-238.
111. Eversole LR, Eversole GM, Kopcik J. Sanguinaria-associated oral leukoplakia, comparison with other benign and dysplastic leukoplakic lesions. Oral Surg Oral Med Oral Path Oral Radiol Endod 2000; 89: 455-464.
112. Scully C, Porter S. Orofacial disease: update for the dental clinical team: 2. Ulcers, erosions and other causes of sore mouth. Part I. Dent Update 1998; 25: 478-84.
113. Gordon SM. The art of acute pain management. Compendium 2007; 28: 248-260.
114. Gapski R, Cobb CM. Chronic inflammatory periodontal disease: a risk factor for cardiovascular stroke and ischemic stroke? Grand Rounds: Oral Syst Med 2006; 1: 14-22.
115. Shannies S, Casey H. The significance of periodontal infection in cardiology. Grand Rounds: Oral Syst Med 2006; 1: 24-33.
116. Rogers RS. III. Recurrent aphthous stomatitis: clinical characteristics and associated systemic disorders. Semin Cutan Med Surg 1997; 16: 278-83.
117. Murray LN, Amedee RG. Recurrent aphthous stomatitis. J Louis State Med Soc 2000; 152: 10-14.
118. Shashy RG, Ridley MB. Aphthous ulcers: A difficult clinical entity. Am J Otolaryngol 2000; 21: 389-93.
119. McBride DR. Management of aphthous ulcers. Am Fam Phys 2000; 62: 149-54, 160.
120. Anderson PM, Schroeder G, Skubitz KM. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 1998; 83: 1433-9.
121. List MA, Siston A, Haraf D, et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 1999; 17: 1020-8.
122. Sonis ST, Eilers JP, Epstein JB, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 1999; 85: 2103-11.
123. Oneschuk D, Hanson J, Bruera E. A survey of mouth pain and dryness in patients with advanced cancer. Supp Care Cancer 2000; 8: 372-6.
124. Eversole LR. Immunopathogenesis of oral lichen planus and recurrent aphthous stomatitis. Semin Cutan Med Surg 1997; 16: 284-94.
125. Sun A, Chu CT, Liu BY, Wang JT, Leu JS, Chiang CP. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated. by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers. Proc Nat Sci Coun Rep China B 2000; 24: 116-22.
126. Buno IJ, Huff, JC, Weston WL, Cook DT, Brice SL. Elevated levels of interferon gamma, tumor necrosis factor alpha, interleukins 2, 4, and 5, but not interleukin 10, are present in recurrent aphthous stomatitis. Arch Derm 1998; 134: 827-31.
127. Natah SS, Hayrinen-Immonen R, Hietanen J, et al. Increased density of lymphocytes bearing gamma/delta T-cell receptors in recurrent aphthous ulceration. Int J Oral Max Surg 2000; 29: 375-80.
128. Ghodratnama F, Wray D, Bagg J. Detection of serum antibodies against cytomegalovirus, varicella zoster virus and human herpesvirus 6 in patients with recurrent aphthous stomatitis. J Oral Pathol Med 1999; 28: 12-5.
129. Brice SL, Cook D, Leahy M, Huff JC, Weston WL. Examination of the oral mucosa and peripheral blood cells of patients with recurrent aphthous ulceration for human herpes virus DNA. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89: 193-8.
130. Loesche WJ, Taylor GW, Dominguez LD, Grossman NS, Stoll J. Factors which are associated with dental decay in the older individual. Gerodontology 1999; 16: 37-46.
131. Rydholm M, Strang PJ. Acupuncture for patients in hospital-based home care suffering from xerostomia. Pall Care 1999; 15: 20-3.
132. Goldin GF, Marcinkiewicz M, Zbroch T, Bityutskiy LP, McCallum RW. Esophago-protective potential of cisapride. An additional benefit for gastroesophageal reflux disease. J Dig Dis Sci 1997; 42: 1362-9.
133. Matear DW. Demonstrating the need for oral health education in geriatric institutions. Probe 1999; 33: 66-71.
134. Strombeck B, Ekdahl C, Manthorpe R, Wikstrorn I, Jacobsson L. Health-related quality of life in primary Sjogren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 2000; 29: 20-8.
135. Astor FC, Hanft KL, Ciocon JO. Xerostomia: a prevalent condition in the elderly. Ear Nose Throat J 1999; 78: 476-9.
136. Chavez EM, Taylor GW, Borrell LN, Ship JA. Salivary function and glycemic control in older persons with diabetes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89: 305-11.
137. Kieser J, Jones G, Borlase G, MacFadyen E. Dental treatment of patients with neurodegenerative disease. N Z Dent J 1999; 95: 130-4.
138. Niedermeier W, Matthaeus C, Meyer C, Staar S, Muller RP, Schulze HJ. Radiation-induced hyposalivation and its treatment with oral carpine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 541-9.
139. Henson BS, Eisbruch A, D'Hondt E, Ship JA. Two-year longitudinal study of parotid salivary flow rates in head and neck cancer patients receiving unilateral neck parotid-sparing radiotherapy treatment. Oral Oncol 1999; 35: 234-41.
140. Oxholm P, Prause JU, Schiodt M. Rational drug therapy recommendations for the treatment of patients with Sjogren's syndrome. Drugs 1998; 56: 345-53.
141. Russell SL, Reisine S. Investigation of xerostomia in patients with rheumatoid arthritis. JADA 1998; 129: 733-9.
142. Vivino FB, Al-Hashimi I, Khan Z, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 1999; 159: 174-81.
143. Rhodus NL, Bereuter J. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjogren's syndrome. J Otolaryngol 2000; 29: 28-34.
144. Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ, Jr. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89: 299-304.
145. Chaushu G, Bercovici M, Dori S, et al. Salivary flow and its relation with oral symptoms in terminally ill patients. Cancer 2000; 88: 984-7.
146. Ben Aryeh H, Gottlieb I, Ish-Shalom S, David A, Szargel H, Laufer D. Oral complaints related to menopause. Maturitas 1996; 24: 185-9.
147. Streckfus CF, Johnson RB, Nick T, Tsao A, Tucci M. Comparison of alveolar bone loss, alveolar bone density and second metacarpal bone density, salivary and gingival crevicular fluid interleukin-6 concentrations in healthy premenopausal and postmenopausal women on estrogen therapy. J Gerontol A Biol Sci Med Sci 1997; 52: 343-51.
148. Streckfus CF, Baur U, Brown LJ, Bacal C, Metter J, Nick T. Effects of estrogen status and aging on salivary flow rates in healthy Caucasian women. Gerontology 1998; 44: 32-9.
149. Myers A, Naylor GD. Glossodynia as an oral manifestation of sex hormone alterations. Ear Nose Throat J 1992; 68: 786-90.
150. Forabosco A, Criscuolo M, Coukos G, et al. Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol 1992; 73: 570-4.
151. Pelissier A. Menopause, hormone replacement treatment (HRT), stomatologic pathologies. Contracept Fertil Sex 1998; 26: 439-43.
152. Laine M, Leimola-Virtanen R. Effect of hormone replacement therapy on salivary flow rate, buffer effect and pH on perimenopausal and postmenopausal women. Arch Oral Biol 1996; 41: 91-6.
153. Glick D, Ben-Aryeh H, Gutman D, Szargel R. Relation between idiopathic glossodynia and salivary flow rate and content. Int J Oral Surg 1976; 5: 161-5.
154. Wardrop RW, Hailes J, Burger H, Reade PC. Oral discomfort at menopause. Oral Surg Oral Med Oral Pathol 1989; 67: 535-40.
155. Trombelli L, Mandrioli S, Zangari F, Saletti C, Calura G. Oral symptoms in the climacteric. A prevalence study. Minerva Stomatol 1992; 41: 507-13.
156. Zakrzewska JM. Women as dental patients: are there any gender differences? Int Dent J 1996; 46: 48-57.
157. MacPhail L. Topical and systemic therapy for recurrent aphthous stomatitis. Semin Cutan Med Surg 1997; 16: 301-7.
158. Holbrook WP, Kristmundsdottir T, Loftsson T. Aqueous hydrocortisone mouthwash solution: clinical evaluation. Acta Odontol Scand 1998; 56: 157-60.
159. Carpenter WM, Silverman S, Jr. Over-the-counter products for oral ulcerations. J Calif Dent Assoc 1998; 26: 199-201.
160. Popovsky JL, Camisa C. New and emerging therapies for diseases of the oral cavity. Dermatol Clin 2000; 18: 113-25.
161. Burruano F, Tortorici S. Major aphthous stomatitis (Sutton's disease): etiopathogenesis, histological and clinical aspects. Minerva Stomatol 2000; 49: 41-50.
162. Peuckmann V, Fisch M, Bruera E. Potential novel uses of thalidomide: focus on palliative care. Drugs 2000; 60: 273-92.
163. Blom M, Kopp S, Lundeberg T. Prognostic value of the pilocarpine test to identify patients who may obtain long-term relief from xerostomia by acupuncture treatment. Arch Otolaryngol Head Neck Surg 1999; 25: 561-566.
164. McFerren MA, Rodriguez E. Piscicidal properties of piperovatine from Piper piscatorum (Piperaceae). J Ethnopharmacol 1998; 60: 183-7.
165. McFerren MA, Cordova D, Rodriguez E, Rauh JJ. In vitro neuropharmacological evaluation of piperovatine, an isobutylamide from Piper piscatorum (Piperaceae). J Ethnopharmacol 2002; 83: 201-7.
166. Dunstan WR, Garnett H. The constituents of Piper ovatum. J Chem Soc 1895; 67: 94-100.
167. Pring BG. Isolation and identification of amides from Piper callosum. Synthesis of pipercallosine and pipercallosidine. J. Chem. Soc., Perkin Trans. I 1982; 1493-1498.
168. Zhou L, Yang J, Tu G. Chemical compounds of Piper hancei. Zhongcaoyao 2005; 36: 13-15.
169. Facundo VA, da Silveira ASP, Morais SM. Constituents of Piper alatabaccum Trel & Yuncker (Piperaceae). Biochem Syst Ecol 2005; 33: 753-756.
170. Giesbrecht AM, De Alvarenga MA, Gottlieb OR, Gottlieb HR. The chemistry of Brazilian Piperaceae. Part V. (2E,4E)-N-Isobutyl-piperonyl-nona-2,4-dienoic amide from Ottonia anisum. Planta Med 1981; 43: 375-377.
171. Soares Costa S, Mors WB. Amides of Ottonia corcovadensis. Phytochemistry 1981; 20: 1305-1307.
172. 13C chemical shift assignments. Quim Nova 2004; 27: 79-83.
173. Haensel R, Leuschke A, Bohlmann F. A new isobutylamide from Ottonia ovata. Planta Med 1980; 40: 161-163.
174. Price SJ, Pinder AR. Chemistry of Ottonia vahlii. II. Constitution of the nonvolatile component. J Org Chem 1970; 35: 2568-2570.
175. Ribiero O, Machado A, Botafogo C. Active principle of Piper jaborandi. Velloso Eng Quim 1952; 4: 16-18, 24.
176. Scott IM, Puniani E, Jensen H, et al. Analysis of Piperaceae germplasm by HPLC and LC-MS: A method for isolating and identifying unsaturated amides from Piper spp. extracts. J Agr Food Chem 2005; 53: 1907-1913.
177. Scott IM, Jensen H, Scott JG, Isman MB, Arnason JT, Philogene BJR. Botanical insecticides for controlling agricultural pests: Piperamides and the Colorado potato beetle Leptinotarsa decemlineata Say (Coleoptera: Chrysomeildae). Arch Insect Biochem Physiol 2003; 54: 212-225.
178. Scott IM, Gagnon N, Lesage L, Philogene BJ, Arnason JT. Efficacy of botanical insecticides from Piper species (Piperaceae) extracts for control of European chafer (Coleoptera: Scarabaediae). J Econ Entomol 2005; 98: 845-855.
179. De Mattos Duarte C, De Araujo Junior JX, Paz Parente J, Barreiro JE. Synthesis of new hypotensive piperamide analogs. Rev Bras Farm 1999; 80: 35-38.
180. Cordell GA. What's in a Name? Evaluating the Safety and Potency of Commercial Phytotherapeutical Products. In "Proceedings of the International Forum on Traditional Medicine", Toyama, Japan. 2001; p. 17-26.
181. Gupta M, Monge A, Karikas G, et al. Screening of Panamanian medicinal plants for brine shrimp toxicity, crown gall tumor inhibition, cytotoxicity and DNA intercalation. Int J Pharmacog 1996; 34: 19-27.
182. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-75.
183. 13C NMR assignments of dihydropipataline, the main of four long-chain 1-(3,4-methylenedioxyphenyl)-alkanes from Piper darienense. Spectroscopy 2000; 14: 195-201.
184. De Oliveira Santos BV, De Oliveira Chaves MC. (E,E)-N-Isobutyl-2,4-octadienamide from Piper marginatum. Biochem Syst Ecol 1999; 27: 113-114.
185. Loub WD, Farnsworth NR, Soejarto DD, Quinn ML. J Chem Inform Comp Sci 1985; 25: 99-105.
186. Fong HHS, Soejarto DD, Cordell GA, Waller GP, Bingel AS. The Search for Fertility Regulating Agents from Plants-An Odyssey. In: Proceedings of the Second International Symposium on Recent Advances in Natural Products Research, Natural Products Research Institute, Seoul National University, Seoul, Korea. 1990; 104-115.
187. Kinghorn AD, Farnsworth NR, Beecher CWW, et al. Novel Strategies for the Discovery of Plant-Derived Anticancer Agents. In: New Trends in Natural Product Chemistry, Atta-ur-Rahman, Chaudhary MI Eds Chur, Harwood Academic Publishers. 1998; 79-94.
188. Kinghorn AD, Farnsworth NR, Soejarto DD, et al. Novel Strategies for the Discovery of Plant-derived Anticancer Agents. Pharmaceut Biol 2003; 41(Suppl): 53-67.